Provided by Tiger Trade Technology Pte. Ltd.

AlphaTON Capital Corp.

1.30
+0.390042.86%
Pre-market: 1.05-0.2500-19.23%06:35 EST
Volume:174.31M
Turnover:373.74M
Market Cap:10.64M
PE:-0.23
High:3.30
Open:1.82
Low:1.30
Close:0.9100
52wk High:15.82
52wk Low:0.5580
Shares:8.19M
Float Shares:6.74M
Volume Ratio:16.41
T/O Rate:2586.75%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.7202
EPS(LYR):-5.7202
ROE:-541.81%
ROA:-92.69%
PB:-86.53
PE(LYR):-0.23

Loading ...

AlphaTON (Nasdaq:ATON) and Cyncado Therapeutics: Preclinical Mesothelioma Data Show Direct A2B Tumor Activity; TT-4 Achieved >90% Tumor Growth Inhibition; First-Patient Dosing on Track for Q1 2026

GlobeNewswire
·
Oct 27, 2025

AlphaTON Capital appoints Wes Levitt as CFO

TIPRANKS
·
Oct 24, 2025

BRIEF-Alphaton Capital Appoints Wes Levitt As Chief Financial Officer

Reuters
·
Oct 24, 2025

Enzo Villani, Chief Investment Officer of AlphaTON Capital, to Speak at the Vatican’s 10th Anniversary World Changers Summit

GlobeNewswire
·
Oct 20, 2025

AlphaTON Capital, SkyBridge Capital discuss crypto innovation, cancer research

TIPRANKS
·
Oct 14, 2025

AlphaTON Capital files to sell 7.47M ordinary shares for holders

TIPRANKS
·
Oct 11, 2025

AlphaTON Capital Receives Nasdaq Congratulations for Groundbreaking Cancer Research Tokenization Initiative

GlobeNewswire
·
Oct 10, 2025

Top Midday Gainers

MT Newswires Live
·
Oct 09, 2025

BUZZ-U.S. STOCKS ON THE MOVE-Datadog, First Majestic, Best Buy

Reuters
·
Oct 09, 2025

BUZZ-AlphaTON Capital skyrockets on blockchain-based cancer drug funding plans

Reuters
·
Oct 09, 2025

Nasdaq Gains 150 Points; US Mortgage Applications Decline

Benzinga
·
Oct 08, 2025

AlphaTON Capital, Subsidiary Tarus Therapeutics Explore Tokenization of Mesothelioma Drug TT-4 Economics

MT Newswires Live
·
Oct 08, 2025

Top Premarket Gainers

MT Newswires Live
·
Oct 08, 2025

Alphaton Capital Corp - Announces Loi to Evaluate Tokenization for Tt-4 in Mesothelioma

THOMSON REUTERS
·
Oct 08, 2025

Alphaton Capital Corp - Loi Is Exploratory and Non-Binding With No Terms Finalized

THOMSON REUTERS
·
Oct 08, 2025

Alphaton Capital Corp - Cynado Targets Tt-4 First-Patient Dosing for Q1 2026

THOMSON REUTERS
·
Oct 08, 2025

What's Behind AlphaTON Capital's 123% After-Hours Spike?

Benzinga
·
Oct 08, 2025

Health in Tech Inc - Co and Alphaton Sign Loi to Develop Hitchain

THOMSON REUTERS
·
Sep 30, 2025

Alphaton Capital Corp Successfully Closes $71 Million Financing and Completes Initial Ton Token Acquisition

THOMSON REUTERS
·
Sep 26, 2025

Press Release: AlphaTON Capital Corp Successfully Closes $71 million Financing and Completes Initial TON Token Acquisition

Dow Jones
·
Sep 26, 2025